Beta Bionics Inc reports results for the quarter ended June 30 - Earnings Summary
29/07/2025 22:01
Beta Bionics Inc BBNX.OQ reported a quarterly adjusted loss of 39 cents per share for the quarter ended June 30. The mean expectation of nine analysts for the quarter was for a loss of 45 cents per share. Wall Street expected results to range from -70 cents to -33 cents per share. Revenue was $23.24 million; analysts expected $19.68 million. Beta Bionics Inc's reported EPS for the quarter was a loss of 39 cents. The company reported a quarterly loss of $16.87 million. Beta Bionics Inc shares had fallen by 3.9% this quarter. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 5.9% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" Wall Street's median 12-month price target for Beta Bionics Inc is $26.00, about 46.2% above its last closing price of $13.99 This summary was machine generated from LSEG data July 29 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Jun. 30 2025 | -0.45 | -0.39 | Beat |
| Mar. 31 2025 | -0.48 | -0.93 | Missed |
| Dec. 31 2024 | -0.47 | -2.72 | Missed |